HealthUnlocked

Redirect Notice

Looks like you clickedhttps://www.urotoday.com/conference-highlights/esmo-2018/esmo-2018-prostate-cancer/107706-esmo-2018-era-223-a-phase-3-trial-of-radium-223-in-combination-with-abiraterone-acetate-and-prednisone-prednisolone-for-the-treatment-of-asymptomatic-or-mildly-symptomatic-chemotherapy-naive-patients-with-bone-predominant-mcrpc.html

If you do not want to visit that page, you can close this browser tab.